Neoadjuvant chemo-immunotherapy still not as nice as neoadjuvant chemoradiation therapy for locally advanced esophageal carcinoma.
Autor: | Rochefort MM; Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Wee JO; Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of thoracic disease [J Thorac Dis] 2024 Jul 30; Vol. 16 (7), pp. 4829-4831. Date of Electronic Publication: 2024 Jul 26. |
DOI: | 10.21037/jtd-24-222 |
Abstrakt: | Competing Interests: Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-222/coif). The authors have no conflicts of interest to declare. |
Databáze: | MEDLINE |
Externí odkaz: |